HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study

HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study

Background: Eosinophilic chronic rhinosinusitis (ECRS) is a subtype of chronic rhinosinusitis with nasal polyps in Japanese. ECRS highly associated with asthma is a refractory eosinophilic airway inflammation and requires comprehensive care as part of the united airway concept. We recently reported...

Full description

Bibliographic Details
Main Authors: Yoshiki Kobayashi, Hirotaka Yasuba, Mikiya Asako, Takahisa Yamamoto, Hiroshi Takano, Koichi Tomoda, Akira Kanda, Hiroshi Iwai
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Immunology
Subjects:
airway medicine
asthma
eosinophilic chronic rhinosinusitis
exhalation through the nose
inhaled corticosteroid
united airway
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02192/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2018.02192/full

Similar Items